800-845-6913
Tuteur Law Networks | Knowledge is Power.
August 16, 2007
August 2007 Leverkusen, Germany and West Haven, Connecticut, USA. – Today, Bayer HealthCare reported findings of Mr. William Taylor’s independent investigation on the i3 Drug Safety observational study on Trasylol® (aprotinin injection) to the U.S. Food and Drug Administration (FDA) and other relevant regulatory authorities and also conveyed actions the company has taken to ensure that this sort of mistake is never again repeated. Mr. Taylor’s full report and information regarding enhanced company practices and procedures have been posted on company websites. Continue reading, ‘08-16-2007 | Bayer Reports Findings of Trasylol Independent Investigation.’